Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Thyroid malignancies are among the most common endocrine cancers worldwide. Owing to the angiogenic nature of these malignancies, tyrosine kinase inhibitors (TKIs) are an attractive potential treatment. |